Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers
Clicks: 170
ID: 273738
2021
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
170 views
30 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #48 of 95 articles by views in acta neuropathologica communications
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Synaptic pathology is a central event in Alzheimer’s disease (AD) and other neurodegenerative conditions, and investigation of synaptic proteins can provide valuable tools to follow synaptic dysfunction and loss in these diseases. Neuroligin-1 ...
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (34 words).
Try re-searching for a better abstract.
| Reference Key |
becker2021actaneuroligin-1
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Elena Camporesi, Tammaryn Lashley, Johan Gobom, Juan Lantero-Rodriguez, Oskar Hansson, Henrik Zetterberg, Kaj Blennow, Bruno Becker;Elena Camporesi;Tammaryn Lashley;Johan Gobom;Juan Lantero-Rodriguez;Oskar Hansson;Henrik Zetterberg;Kaj Blennow;Bruno Becker; |
| Journal | acta neuropathologica communications |
| Year | 2021 |
| DOI |
10.1186/s40478-021-01119-4
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.